BLRX — BIOLINE RX LIMITED
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Sep 2026 | -0.38 | — | 0.00 | -0.77 | 2 | — |
| Dec 2026 | -0.40 | — | 0.00 | -0.80 | 2 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -1.57 | — | 0.00 | -3.14 | 2 | — |
| Dec 2027 | -1.26 | — | 0.00 | -2.52 | 2 | — |
| Dec 2028 | 0.00 | — | 0.00 | 0.00 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 17 SEC-registered investment managers reported holding BLRX (BIOLINE RX LIMITED) in their latest 13F filings, with a combined reported value of $1.33M across 567.77K shares. That is +12.5% by share count (+8.25K shares) versus the previous quarter, while reported value moved -14.9%. Ownership is concentrated: the five largest holders account for 99.1% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 5 opened new positions, 4 added to existing stakes, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of BIOLINE RX LIMITED (BLRX) include SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 63 institutional holders on this page.
BLRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 17 | 567.77K | $1.33M | +12.5% |
| Q2 2026 | 15 | 66.60K | $1.21M | +93.9% |
| Q1 2026 | 13 | 29.80K | $68.79K | -21.9% |
| Q4 2025 | 14 | 22.80K | $64.52K | -30.6% |
| Q3 2025 | 15 | 47.99K | $181.42K | +31.4% |
| Q2 2025 | 18 | 52.55K | $240.34K | +14.7% |
| Q1 2025 | 12 | 9.46K | $28.00K | -95.8% |
| Q4 2024 | 30 | 1.92M | $408.12K | -11.6% |
Over the 8 quarters shown, institutional share counts decreased 70% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (-95.8%).
Top Institutional Holders (Q3 2026) — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 473.00K | $1.11M | 0.01% | New | |
| 30.09K | $70.70K | 0.00% | Add | |
| 20.55K | $48.30K | 0.00% | Reduce | |
| 20.04K | $47.10K | 0.00% | New | |
| 18.90K | $44.41K | 0.00% | Add | |
| 2.48K | $5.82K | 0.00% | Hold | |
| 1.75K | $4.11K | 0.00% | Reduce | |
| 250 | $588 | 0.00% | Hold | |
| 200 | $470 | 0.00% | New | |
| 181 | $425 | 0.00% | New | |
| 157 | $369 | 0.00% | Add | |
| 82 | $193 | 0.00% | Hold | |
| 51 | $119 | 0.00% | Add | |
| 28 | $66 | 0.00% | Hold | |
| 10 | $24 | 0.00% | Hold | |
| 2 | $5 | 0.00% | New | |
| 2 | $5 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $1.00M | 0.00% | New | |
| 30.91K | $95.82K | 0.00% | Add | |
| 15.41K | $48.09K | 0.00% | New | |
| 14.80K | $45.87K | 0.00% | New | |
| 2.48K | $7.68K | 0.00% | Add | |
| 2.00K | $6.24K | 0.00% | Add | |
| 500 | $1.55K | 0.00% | Reduce | |
| 250 | $780 | 0.00% | Hold | |
| 101 | $315 | 0.00% | Reduce | |
| 82 | $256 | 0.00% | Reduce | |
| 28 | $87 | 0.00% | New | |
| 26 | $81 | 0.00% | Hold | |
| 10 | $31 | 0.00% | New | |
| 2 | $6 | 0.00% | Hold | |
| 1 | $3 | 0.00% | Reduce |
Q1 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.94K | $25.27K | 0.00% | New | |
| 10.20K | $23.56K | 0.00% | New | |
| 2.35K | $5.43K | 0.00% | Reduce | |
| 1.80K | $4.14K | 0.00% | Add | |
| 1.75K | $4.03K | 0.00% | Hold | |
| 1.73K | $3.99K | 0.00% | Reduce | |
| 529 | $1.22K | 0.00% | Reduce | |
| 250 | $575 | 0.00% | Hold | |
| 107 | $247 | 0.00% | Hold | |
| 100 | $230 | 0.00% | Hold | |
| 26 | $59 | 0.00% | Hold | |
| 12 | $28 | 0.00% | Hold | |
| 2 | $5 | 0.00% | Hold |
Q4 2025 — 14 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.60K | $33.06K | 0.00% | Add | |
| 3.35K | $9.55K | 0.00% | Add | |
| 2.04K | $5.81K | 0.00% | New | |
| 1.95K | $5.40K | 0.00% | Reduce | |
| 1.75K | $4.85K | 0.00% | Hold | |
| 1.50K | $4.16K | 0.00% | New | |
| 250 | $693 | 0.00% | Hold | |
| 107 | $296 | 0.00% | Hold | |
| 100 | $285 | 0.00% | Reduce | |
| 100 | $277 | 0.00% | Reduce | |
| 26 | $71 | 0.00% | Add | |
| 12 | $33 | 0.00% | Hold | |
| 10 | $28 | 0.00% | Add | |
| 2 | $6 | 0.00% | Hold |
Q3 2025 — 15 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 20.20K | $76.36K | 0.00% | Add | |
| 10.02K | $37.88K | 0.00% | Reduce | |
| 6.39K | $24.14K | 0.00% | New | |
| 5.95K | $22.50K | 0.00% | Add | |
| 3.07K | $11.60K | 0.00% | Reduce | |
| 1.75K | $6.62K | 0.00% | Hold | |
| 250 | $945 | 0.00% | Hold | |
| 200 | $756 | 0.00% | Reduce | |
| 107 | $405 | 0.00% | Hold | |
| 39 | $147 | 0.00% | New | |
| 12 | $45 | 0.00% | New | |
| 2 | $8 | 0.00% | Hold | |
| 2 | $8 | 0.00% | Hold | |
| 2 | $8 | 0.00% | Hold | |
| 1 | $3 | 0.00% | Hold |
Q2 2025 — 18 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.82K | $63.14K | 0.01% | New | |
| 12.20K | $55.75K | 0.00% | New | |
| 11.10K | $50.72K | 0.00% | New | |
| 4.28K | $19.53K | 0.00% | Add | |
| 4.00K | $18.30K | 0.00% | New | |
| 3.00K | $13.00K | 0.00% | New | |
| 1.75K | $8.00K | 0.00% | Reduce | |
| 1.54K | $7.05K | 0.00% | Reduce | |
| 400 | $1.83K | 0.00% | Add | |
| 250 | $1.14K | 0.00% | Reduce | |
| 2 | $914 | 0.00% | New | |
| 107 | $489 | 0.00% | Hold | |
| 72 | $329 | 0.00% | New | |
| 25 | $114 | 0.00% | New | |
| 2 | $9 | 0.00% | Hold | |
| 2 | $9 | 0.00% | Hold | |
| 2 | $9 | 0.00% | Hold | |
| 1 | $4 | 0.00% | New |
New Positions (Q3 2026)
- ARMISTICE CAPITAL, LLC 473.00K sh · $1.11M
- STIFEL FINANCIAL CORP 20.04K sh · $47.10K
- SIMPLEX TRADING, LLC 200 sh · $470
- Tower Research Capital LLC (TRC) 181 sh · $425
- Caitong International Asset Management Co., Ltd 2 sh · $5
Fully Exited (vs previous quarter)
- Banque Cantonale Vaudoise sold 1 sh · $1.00M
- BNP PARIBAS FINANCIAL MARKETS sold 500 sh · $1.55K
- Citigroup Inc sold 1 sh · $3
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 473.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 30.09K | 14.80K | — | 11.60K | 10.02K | 12.20K | — | 5.10K | 6.30K | 11.20K | 12.20K | 4.40K | 4.20K | 257.67K | — | — | — | 33.07K | 11.00K | 44.80K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20.55K | 30.91K | 10.20K | — | 20.20K | 11.10K | — | 87.22K | 18.03K | 110.50K | 172.10K | 80.00K | 103.00K | — | — | — | — | — | — | — |
| STIFEL FINANCIAL CORP | 20.04K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 18.90K | 15.41K | — | — | — | — | — | — | — | — | — | — | — | 98.71K | 106.09K | 257.90K | 68.22K | 45.74K | 67.35K | 14.10K |
| RHUMBLINE ADVISERS | 2.48K | 2.48K | 2.35K | 3.35K | 3.07K | 4.28K | 1.53K | 42.96K | 32.61K | 25.74K | 18.33K | 18.80K | 15.34K | — | — | — | — | — | — | — |
| Wells Fargo & Co | 1.75K | 2.00K | 1.75K | 1.75K | 1.75K | 1.75K | 3.00K | 5.54K | 35.03K | 56.03K | 32.03K | 8.54K | 8.54K | 35 | 35 | 35 | — | — | — | 703 |
| Nemes Rush Group LLC | 250 | 250 | 250 | 250 | 250 | 250 | 300 | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | 12.00K | — | — | — | — | — | — | — |
| SIMPLEX TRADING, LLC | 200 | — | — | — | — | 3.00K | — | — | 3.10K | 2.80K | 1.98K | 6.40K | 1.20K | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 181 | — | — | — | 39 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 157 | 101 | 529 | 1.95K | 6.39K | — | 71 | 9.20K | 984 | 1.48K | 12.57K | 300 | 9.28K | 10.54K | — | 3.83K | 12.79K | — | — | — |
| NewEdge Advisors, LLC | 82 | 82 | 107 | 107 | 107 | 107 | 107 | 4.30K | 4.30K | 4.30K | 4.30K | 4.30K | 4.30K | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 51 | 26 | 26 | 26 | 1 | 1 | — | 1.21K | 1.21K | 1.41K | 1.21K | 14.32K | 24.20K | — | — | — | — | — | — | — |
| BFC Planning, Inc. | 28 | 28 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 10 | 10 | — | — | 2 | 2 | 2 | 3.10K | — | — | — | — | — | — | — | — | — | — | — | — |
| DANSKE BANK A/S | 2 | 2 | 2 | 2 | 2 | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| SABBY MANAGEMENT, LLC | — | — | — | — | — | — | — | — | — | — | — | — | 210.00K | — | — | — | — | — | — | — |
| Alyeska Investment Group, L.P. | — | — | — | — | — | — | — | — | 866.50K | 1.95M | — | — | — | — | — | — | — | — | — | — |
| Banque Cantonale Vaudoise | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold BLRX?
As of 2026-Q3, 17 institutional funds reported holding BLRX (BIOLINE RX LIMITED) in SEC 13F filings, with a combined reported value of $1.33M.
How many shares of BLRX do institutions own?
13F filers reported 567.77K shares of BLRX, worth $1.33M in aggregate at the end of 2026-Q3.
Is institutional ownership of BLRX rising or falling?
Share counts moved +12.5% versus the prior quarter — accumulation.
Who are the top institutional holders of BLRX?
The largest 13F holders are SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, Banque Cantonale Vaudoise, Alyeska Investment Group, L.P.; the top 25 are ranked at the top of this page.
Who are the major shareholders of BIOLINE RX LIMITED?
The major shareholders of BIOLINE RX LIMITED (BLRX) by reported 13F value are SABBY MANAGEMENT, LLC, ARK Invest, ARMISTICE CAPITAL, LLC, Banque Cantonale Vaudoise, Alyeska Investment Group, L.P., among 63 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.